About 100 reports

  • SPINAL CORD STIMULATION DEVICES MARKET, BY REGION, 2015-2022 (USD MILLION)

Spinal cord stimulation involves the implantation of an implanted pulse generator (IPG) in the spinal cord to provide pain relief.

  • Neurological Disorder
  • Abbott Laboratories, Inc.
  • AxoGen, Inc.
  • Boston Scientific Corporation
  • Medtronic, Inc.

Quell is available as over the counter for chronic pain relief.

  • Neurological Disorder
  • Urology Device
  • World
  • Market Size
  • Boston Scientific Corporation
  • HIGH INCIDENCE RATES OF BRAIN ANEURYSM AND CEREBRAL DISORDERS

Currently, SCS systems are used for pain relief, but in the future, they will be also used to treat angina and asthma.

  • Neurological Disorder
  • World
  • DePuy Synthes, Inc.
  • Medtronic, Inc.
  • Stryker Corporation
  • DATE
  • Neurological Disorder
  • World
  • Boston Scientific Corporation
  • Cyberonics, Inc.
  • Jude Medical, Inc.
  • 7.2.2 BOSTON SCIENTIFIC - NEUROMODULATION PRODUCTS PORTFOLIO
  • 7.3.2 ST. JUDE MEDICAL - NEUROMODULATION PRODUCTS PORTFOLIO
  • Neurological Disorder
  • World
  • Boston Scientific Corporation
  • Cyberonics, Inc.
  • Jude Medical, Inc.

Global pacemaker electrodes market 2016-2021 ($ millions) Global pacemaker electrodes market: Year-over-year growth 2017-2021 (%) TENS electrodes TENS is used in pain relief therapies.

  • Medical Equipment
  • Neurological Disorder
  • World
  • Forecast
  • Medtronic, Inc.

In March 2015, Medtronic launched a nationwide pain relief campaign in Kuwait.

  • Neurological Disorder
  • Market Size
  • Flowonix Medical, Inc.
  • Medtronic, Inc.
  • Teleflex Incorporated

pain relief solutions KEY HIGHLIGHTS PART ##: Appendix List of abbreviations MEG magnetoencephalography polysomnography PSG PART ##: Explore Technavio Our team of ## specialized market research analysts continuously monitor and evaluate the global market landscape.

  • Neurological Disorder
  • Neurological Monitoring
  • Compumedics Limited
  • Natus Medical Incorporated
  • Nihon Kohden Corporation
  • INCREASING RESEARCH STUDIES ON ELECTRICAL STIMULATION

THE DEVICE INHIBITS THE PAIN SIGNALS BEFORE THEY REACH THE BRAIN, THUS LEADING TO INDIVIDUALS EXPERIENCING PAIN RELIEF.

  • Neurological Disorder
  • World
  • Boston Scientific Corporation
  • Jude Medical, Inc.
  • Medtronic, Inc.
  • INCREASING FOCUS ON RESEARCH

These initiatives enable the efforts to increase awareness among various stakeholders regarding the growing disease burden as well as the technological advances for rapid muscular and pain relief.

  • Neurological Disorder
  • Boston Scientific Corporation
  • Jude Medical, Inc.
  • Medtronic, Inc.
  • Sonova Holding AG

IT OFFERS PAIN RELIEF AND ANTI-INFLAMMATORY PROPERTIES.

  • Neurological Disorder
  • Allergan plc
  • Ipsen S.A.
  • Pfizer Inc.
  • Teva Pharmaceuticals Ltd.

THE PAIN THERAPIES DIVISION OFFERS NEUROSTIMULATION SYSTEMS AND IMPLANTABLE DRUG INFUSION SYSTEMS FOR THE MANAGEMENT OF CHRONIC PAIN.

  • Neurological Disorder
  • Compumedics Limited
  • Medtronic, Inc.
  • Natus Medical Incorporated
  • Nihon Kohden Corporation
  • SPINAL CORD STIMULATION MARKET SIZE, BY REGION, 2013-2020 ($MILLION)
  • KEY FINDINGS

This release enabled the company to provide pain relief to a broader spectrum of patients suffering from chronic pain.

  • Neurological Disorder
  • World
  • Boston Scientific Corporation
  • Jude Medical, Inc.
  • Medtronic, Inc.

The pain relief induced by analgesics occurs either by blocking pain signals going to the brain or by interfering with the brain' s interpretation of the signals, without producing anesthesia or loss of consciousness.

  • Neurological Disorder
  • United States
  • Auspex Pharmaceuticals, Inc.
  • Cephalon, Inc.
  • ChemGenex Pharmaceuticals Limited
  • CHRONIC SHOULDER PAIN

TODAY, SPR (" STIMULATION FOR PAIN RELIEF" ) THERAPEUTICS OFFERS ITS LEAD PRODUCT, THE SMARTPATCH PNS SYSTEM, FOR CHRONIC POST-STROKE SHOULDER PAIN.

  • Neurological Disorder
  • United States
  • Bioness Inc.
  • Boston Scientific Corporation
  • Cyberonics, Inc.

Complex regional pain syndrome (CRPS) is a chronic pain condition that most often affects one limb usually after an injury.

  • Neurological Disorder
  • United States
  • World
  • Product Initiative
  • Grunenthal GmbH
  • SMALL MOLECULES TO ANTAGONIZE NMDA RECEPTOR AND CHRNA7 FOR CENTRAL NERVOUS SYSTEM - DRUG PROFILE

Complex regional pain syndrome (CRPS) is a chronic pain condition that most often affects one limb usually after an injury.

  • Neurological Disorder
  • Therapy
  • United States
  • Product Initiative
  • Grunenthal GmbH
  • METACHROMATIC LEUKODYSTROPHY (MLD) - PIPELINE BY ARMAGEN INC, H2 2017
  • METACHROMATIC LEUKODYSTROPHY (MLD) - PIPELINE BY GLAXOSMITHKLINE PLC, H2 2017

The company offers over-the-counter (OTC) products for pain relief, oral health, nutrition, skin health and respiratory diseases.

  • Mental Health
  • Neurological Disorder
  • United States
  • World
  • Product Initiative

THE INCREASING DEMAND FOR MINIMALLY INVASIVE SURGERIES AND TARGETED PAIN RELIEF, COUPLED WITH THE LIMITED SIDEEFFECTS AND COST-EFFECTIVE PAIN RELIEF OFFERED BY NEUROSTIMULATORS ARE DRIVING THE GROWTH OF THIS MARKET SEGMENT.

  • Cardiac Management
  • Medical Device
  • Neurological Disorder
  • World
  • Market Size
  • Diabetic Peripheral Neuropathy - Product Development Milestones

Until now, most of the medications prescribed for diabetic neuropathy have largely been analgesics aimed for pain relief.

  • Neurological Disorder
  • Pathology
  • United States
  • Product Initiative
  • ViroMed Co., Ltd.
  • METACHROMATIC LEUKODYSTROPHY (MLD) - PIPELINE BY ARMAGEN INC, H1 2017
  • METACHROMATIC LEUKODYSTROPHY (MLD) - PIPELINE BY GLAXOSMITHKLINE PLC, H1 2017

The company offers over-the-counter (OTC) products for pain relief, oral health, nutrition, skin health and respiratory diseases.

  • Neurological Disorder
  • United States
  • World
  • Product Initiative
  • ArmaGen

However, these agents although providing relief, are often poorly tolerated, and require lengthy dose escalation, resulting in sub-optimal efficacy.

  • Neurological Disorder
  • Pharmaceutical
  • United States
  • Product Initiative
  • Allergan plc
  • Target
  • Health Services
  • Neurological Disorder
  • Neurology
  • World
  • Product Initiative
  • Clinical Trial profile. 29 Trial Title
  • Clinical Trial Profile Snapshots
  • Mental Health
  • Neurological Disorder
  • Neurology
  • World
  • Product Initiative
  • cGMP manufacturing activities will be conducted at Catalent's primary softgel development and manufacturing facility in St. Petersburg, Florida.

It was under development for fibromyalgia, peripheral neuropathic pain.

  • Neurological Disorder
  • Pharmaceutical
  • United States
  • Product Initiative
  • Neurocrine Biosciences, Inc.

Preclinical study confirmed that RPI-##M had analgesic activity and supports some of the clinical reports of pain relief in subjects with herpes infections and rheumatoid arthritis.

  • Neurological Disorder
  • United States
  • World
  • Product Initiative
  • Viking Therapeutics, Inc.
  • Diabetic Peripheral Neuropathy - Product Development Milestones

The combination drug candidate blocks the ability of peripheral nerve receptors to transmit pain messages to the brain, which in turn provides significant pain relief.

  • Neurological Disorder
  • Pathology
  • United States
  • Product Initiative
  • ViroMed Co., Ltd.
  • CLINICAL TRIAL PROFILE SNAPSHOTS

Complex Regional Pain Syndrome Global Clinical Trials Review, H##, 2017 HEA LTH CA REHEA LTH CA RE REFERENCE CODE: GDHC##CTIDB PUBLICATION DATE: JUN 2017 LIST OF TABLES LIST OF FIGURES COMPLEX REGIONAL PAIN SYNDROME GLOBAL CLINICAL TRIALS REVIEW, H##, 2017 OUTLINES CLINICAL TRIALS

  • Drug Discovery And Development
  • Neurological Disorder
  • Neurology
  • World
  • Product Initiative

Pain Relief after ## Botulinum Toxin Type A (BoNT-A) Injection Cycles in Patients with Post-stroke Lower Limb Spasticity RELIEF Study: Lower Limb Pain Relief After Injection Cycles in Adults Suffering From Lower Limb Spasticity Following Stroke (

  • Neurological Disorder
  • Neurology
  • World
  • Product Initiative
  • Ipsen S.A.

The company offers over-the-counter (OTC) products for pain relief, oral health, nutrition, skin health and respiratory diseases.

  • Neurological Disorder
  • Pharmaceutical
  • United States
  • Product Initiative
  • Lycera Corp.